MedPath

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

HSA:14

Drug Approvals

VYZULTA (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION) 0.024%

Approval Date
Jun 1, 2021
HSA

LANOTAN OPHTHALMIC SOLUTION 0.005% w/w

Approval Date
Aug 27, 2013
HSA

ZYLET® STERILE OPHTHALMIC SUSPENSION

Approval Date
May 4, 2009
HSA

LOTEMAX STERILE OPHTHALMIC SUSPENSION 0.5%

Approval Date
Oct 13, 2004
HSA

MINIMS DEXAMETHASONE SODIUM PHOSPHATE EYE DROPS 0.1% w/v

Approval Date
Sep 6, 2001
HSA

MINIMS PHENYLEPHRINE HYDROCHLORIDE EYE DROPS 2.5% w/v

Approval Date
Oct 2, 1998
HSA

MIOCHOL-E INTRAOCULAR SOLUTION

Approval Date
Mar 18, 1997
HSA

VIVIDRIN EYE DROPS 20 mg/ml

Approval Date
Jun 28, 1990
HSA

DESOMEDINE EYE DROPS 1 mg/ml

Approval Date
May 3, 1990
HSA

MINIMS TROPICAMIDE EYE DROPS 1% w/v

Approval Date
Apr 20, 1990
HSA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.